Answers are grounded in this paper and cite their sources.
Reductions in all-cause mortality, major vascular events and revascularisations were found with no excess of adverse events among people without evidence of CVD treated with statins.
No takes yet. Share an insight, caveat, or question.
Taylor et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: